Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare-Metal Stents in Acute Myocardial Infarction: Two-Year Clinical Results of the COMFORTABLE AMI Trial
暂无分享,去创建一个
L. Räber | A. Baumbach | P. Wenaweser | S. Windecker | B. Meier | T. Lüscher | R. Kornowski | C. von Birgelen | C. Matter | M. Roffi | T. Engstrøm | D. Heg | A. Moschovitis | D. Tüller | G. Pedrazzini | H. Kelbæk | M. Ostojić | K. Weber | P. Jüni | Masanori Taniwaki | Aris Moschovitis
[1] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.
[2] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.
[3] P. Barragan,et al. Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction , 2012, Thrombosis and Haemostasis.
[4] G. Stone,et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. , 2012, Archives of internal medicine.
[5] Marco Valgimigli,et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. , 2012, European heart journal.
[6] L. Räber,et al. Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] F. Eberli,et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. , 2012, European heart journal.
[8] F. Eberli,et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial , 2011, The Lancet.
[9] E. Edelman,et al. Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.
[10] B. Gersh,et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. , 2009, The New England journal of medicine.
[11] H. Putter,et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. , 2008, Journal of the American College of Cardiology.
[12] E. Bramucci,et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. , 2006, The New England journal of medicine.
[13] G. Stone,et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. , 2000, The New England journal of medicine.
[14] Bruce R. Brodie,et al. Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .
[15] P. Kligfield. Primary angioplasty in myocardial infarction. , 1995, British heart journal.
[16] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[17] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.